Screening for STIs is one of the main drivers of macrolide consumption in PrEP users

Cost-effectiveness of two screening strategies for Chlamydia trachomatis and Neisseria gonorrhoeae as part of the PrEP programme in the Netherlands: a modelling study

(2021) Francine van Wifferen et al.   SEXUALLY TRANSMITTED INFECTIONS

Is There a Resistance Threshold for Macrolide Consumption? Positive Evidence from an Ecological Analysis of Resistance Data from Streptococcus pneumoniae, Treponema pallidum, and Mycoplasma genitalium

(2021) Chris Kenyon et al.   Microbial Drug Resistance

Screening for STIs in PrEP cohorts results in high levels of antimicrobial consumption

(2020) Chris Kenyon et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Demographic and behavioural factors associated with antimicrobial susceptibility to azithromycin and ceftriaxone in Neisseria gonorrhoeae

(2020) Rose F Forster et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Daily and event‐driven pre‐exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence

(2019) Bea Vuylsteke et al.   Journal of the International AIDS Society

Is screening for chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? A systematic review of observational studies

(2018) Achilleas Tsoumanis et al.   SEXUALLY TRANSMITTED DISEASES

2016 European guideline on the management of non-gonococcal urethritis

(2016) Patrick J Horner et al.   INTERNATIONAL JOURNAL OF STD & AIDS

2015 European guideline on the management of Chlamydia trachomatis infections

(2015) E Lanjouw et al.   INTERNATIONAL JOURNAL OF STD & AIDS

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

(2013) C Bignell et al.   INTERNATIONAL JOURNAL OF STD & AIDS